Therapieanpassungen mithilfe von Trendpfeilen bei kontinuierlichen Glukosemonitoring (CGM)-Systemen

 

 Buy Article Permissions and Reprints

Zusammenfassung

Die unterschiedlichen Systeme zum kontinuierlichen interstitiellen Glukosemonitoring nutzen Trendpfeile, mit denen dem Anwender in grafischer Form eine Prognose zum künftigen Glukoseverlauf angezeigt wird. Sie werden sowohl beim Glukosemonitoring mit „Real-Time“-Alarmen als auch beim Glukosemonitoring mit intermittierendem Scannen genutzt. Die Trendpfeile sind für viele Menschen mit Diabetes eine wichtige Grundlage für Stoffwechselkorrekturen, weshalb ihre Interpretation zur Voraussetzung für adäquate Therapieentscheidungen wird. Ziel dieser Publikation ist es, auf der Grundlage verfügbarer Vorschläge zur Trendpfeilinterpretation eine allgemein gültige Handlungsanweisung für Diabetesteams und Nutzer von kontinuierlichem Glukosemonitoring mit der Möglichkeit der notwendigen individuellen Anpassung zu geben.

Abstract

Different systems of continuous glucose monitoring utilize graphically displayed trend arrows for the visualization of upcoming glucose trends. The feature can be observed in real-time glucose monitoring as well as in intermittent continuous glucose monitoring systems. In patients with diabetes, trend arrows are frequently considered to be a basis for metabolic corrections. Thus, the interpretation and understanding of trend arrows is a prerequisite for adequate therapy decisions. The aim of this publication is to present strategies for trend arrow interpretations, which can serve as a general guidance for diabetes teams and continuous glucose monitoring users to enable individual adaptations.

• Literatur

• 1 IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006; 23: 579-593
  CrossrefPubMedGoogle Scholar
• 2 Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabetic medicine: a journal of the British Diabetic Association 2008; 25: 1151-1156
  CrossrefPubMedGoogle Scholar
• 3 American Diabetes Association A. Standards of Medical Care in Diabetes – 2016. Diabetes Care 2016; 39 (Suppl. 01) S1-S112
  CrossrefPubMedGoogle Scholar
• 4 Grunberger G, Bailey T, Camacho PM. et al. Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring. Endocr Pract 2015; 21: 522-533
  CrossrefPubMedGoogle Scholar
• 5 National Collaborating Centre for Womens Childrens Health. National Institute for Health and Care Excellence: Clinical Guidelines. In Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management. London: National Institute for Health and Care Excellence (UK). , Copyright (c) 2015 National Collaborating Centre for Women’s and Children’s Health.; 2015
  PubMedGoogle Scholar
• 6 Heinemann L, Freckmann G. CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring. J Diabetes Sci Technol 2015; 9: 947-950
  CrossrefPubMedGoogle Scholar
• 7 Bolinder J, Antuna R, Geelhoed-Duijvestijn P. et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet (London, England) 2016; 388: 2254-2263
  CrossrefPubMedGoogle Scholar
• 8 Danne T, Nimri R, Battelino T. et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017; 40: 1631-1640
  CrossrefPubMedGoogle Scholar
• 9 DDG AdTeVd. Kontinuierliche Glukosemessung (CGM) in der Gewebeflüssigkeit. Wissenschaftliche Bewertung von CGM und medizinische Beurteilung des Nutzens für die Diabetestherapie AGDT-DDG-GKV_CGM-Positionspapier. Available at: 2010 https://de.scribd.com/document/252338406/DDG-Kontinuierliche-Glukosemessung
  PubMedGoogle Scholar
• 10 Horwitz DL, Klonoff DC. New Technologies for Glucose Monitoring and Insulin Adminstration. Chichester, UK: John Wiley & Sons; 2017
  Google Scholar
• 11 Aleppo G. et al. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes. Journal of the Endocrine Society 2017; 1: 1445-1460
  CrossrefPubMedGoogle Scholar
• 12 Institute LaS. Performance metrics for continuous interstitial glucose monitoring; approved Guideline. POCT05-A; 28. No 33. Available at: http://www.clsi.org/source/orders/free/poct05-a.pdf 2008
  Google Scholar
• 13 Pettus J, Edelman SV. Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes. J Diabetes Sci Technol 2017; 11: 138-147
  CrossrefPubMedGoogle Scholar
• 14 Laffel LM, Aleppo G, Buckingham BA. et al. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. Journal of the Endocrine Society 2017; 1: 1461-1476
  CrossrefPubMedGoogle Scholar
• 15 Klonoff DC, Kerr D. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring. J Diabetes Sci Technol 2017; DOI: 10.1177/1932296817723260: 1932296817723260.
  CrossrefGoogle Scholar
• 16 JDRF CGM Study Group. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther 2008; 10: 310-321
  CrossrefPubMedGoogle Scholar
• 17 AGDT. Stellungnahme der AGDT zum Ersatz von Blutglukosemessungen durch Messungen mit Systemen zum kontinuierlichen real-time Glukosemonitoring (rtCGM) oder CGM mit intermittierendem Scannen (iscCGM). Available at: http://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Dokumente_Startseite/Teaser-Box/AGDT_Stellungnahme_Replacement_2016_11_11.pdf
  Google Scholar
• 18 Schmelzeisen-Redeker G, Schoemaker M, Kirchsteiger H. et al. Time Delay of CGM Sensors: Relevance, Causes, and Countermeasures. J Diabetes Sci Technol 2015; 9: 1006-1015
  PubMedGoogle Scholar
• 19 Pleus S, Kamecke U, Link M. et al. Prediction quality of glucose trend indicators in current tissue glucose monitoring systems for use in therapeutic decisions. EASD congress Lisbon 2017. Available at: 2017 https://www.easd.org/virtualmeeting/home.html#!resources/prediction-quality-of-glucose-trend-indicators-in-current-tissue-glucose-monitoring-systems-for-use-in-therapeutic-decisions
  PubMedGoogle Scholar
• 20 AGDT. 2016 http://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Stellungnahmen/2016/AGDT_Stellungnahme_Replacement_20160130-L.pdf
  PubMed
• 21 Diabetes Research In Children Network Study G, Buckingham B, Xing D. et al. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes 2008; 9: 142-147
  CrossrefPubMedGoogle Scholar
• 22 Scheiner G. Practical CGM: Improving Patient Outcomes Through Continuous Glucose Monitoring. VA: American Diabetes Association; 4th. Aufl. Alexandria: American Diabetes Association; 2015
  Google Scholar
• 23 AGDT. SPECTRUM CGM-Schulungs- und Behandlungsprogramm. In. Mainz: Kirchheim Verlag; 2015
  PubMedGoogle Scholar
• 24 Kulzer B. Flash Schulungsset. In. Mainz: Kirchheim Verlag; 2017
  PubMedGoogle Scholar
• 25 Abbott. Abbott Free Style Libre – User Manual. 2017
  PubMedGoogle Scholar
• 26 Dexcom. Dexcom G5 Mobile Bedinungsanleitung. System zur Kontinuierlichen Glukoseüberwachung. 2017
  PubMedGoogle Scholar
• 27 Medtronic. Guardian Connect – Kurzanleitung. 2017
  PubMedGoogle Scholar
• 28 Eversense. Eversense CGM User Guide. 2017
  PubMedGoogle Scholar